Results 31 to 40 of about 22,929 (214)

Global serum glycoform profiling for the investigation of dystroglycanopathies & Congenital Disorders of Glycosylation

open access: yesMolecular Genetics and Metabolism Reports, 2016
The Congenital Disorders of Glycosylation (CDG) are an expanding group of genetic disorders which encompass a spectrum of glycosylation defects of protein and lipids, including N- & O-linked defects and among the latter are the muscular ...
Wendy E. Heywood   +11 more
doaj   +1 more source

Case-control study about the acceptance of Pegvaliase in Phenylketonuria

open access: yesMolecular Genetics and Metabolism Reports, 2020
Introduction: Pegvaliase is a novel enzyme substitution therapy approved by the European Drug Administration (EDA) in May 2019 for the treatment of Phenylketonuria (PKU) in adults and children ≥16 years of age.
Johannes Krämer
doaj   +1 more source

Inborn Errors of Proline Metabolism [PDF]

open access: yesThe Journal of Nutrition, 2008
l-Proline concentration is primarily related to the balance of enzymatic activities of proline dehydrogenase [proline oxidase (POX)] and Delta-1-pyrroline-5-carboxylate (P5C) reductase. As a result, P5C plays a pivotal role in maintaining the concentration of proline in body fluids and inborn errors of P5C metabolism lead to disturbance of proline ...
Hiroshi, Mitsubuchi   +3 more
openaire   +2 more sources

Sustaining benefits of nutritional therapy in young adults with phenylketonuria - A 2 year prospective study

open access: yesMolecular Genetics and Metabolism Reports, 2020
Introduction: Phenylketonuria (PKU) is an inborn error of metabolism, which is caused by a deficiency in the enzyme phenylalanine hydroxylase (PAH). Life-long Phe-free diet impairs quality of life, especially in adolescents and young adults which take ...
Johannes Krämer
doaj   +1 more source

Iduronate-2-sulfatase interactome: validation by yeast two-hybrid assay

open access: yesHeliyon, 2022
Background: Mucopolysaccharidosis type II (MPS II), also known as Hunter syndrome, is a rare X-linked recessive disease caused by a deficiency of the lysosomal enzyme iduronate-2-sulfatase (IDS), which activates intracellular accumulation of ...
Eliana Benincore-Flórez   +6 more
doaj   +1 more source

Lysosomal Acid Lipase Deficiency: Report of Five Cases across the Age Spectrum

open access: yesCase Reports in Pediatrics, 2018
Lysosomal acid lipase (LAL) deficiency is an autosomal recessive lysosomal storage disorder caused by mutations in the LIPA gene that leads to premature organ damage and mortality.
Marco Antonio Curiati   +4 more
doaj   +1 more source

Food or medicine? A European regulatory perspective on nutritional therapy products to treat inborn errors of metabolism [PDF]

open access: hybrid, 2023
Nina N. Stolwijk   +7 more
openalex   +1 more source

Inborn Errors of Bile Acid Metabolism [PDF]

open access: yesSeminars in Liver Disease, 2007
Inborn errors of bile acid metabolism are rare causes of neonatal cholestasis and liver disease in older children and adults. The diagnosis should be considered in the context of hyperbilirubinemia with normal serum bile acids and made by urinary liquid secondary ionization mass spectrometry or DNA testing. Cholic acid is an effective treatment of most
James E, Heubi   +2 more
openaire   +4 more sources

Evidence of epigenetic landscape shifts in mucopolysaccharidosis IIIB and IVA

open access: yesScientific Reports
Lysosomal storage diseases (LSDs) are a group of monogenic diseases characterized by mutations in genes coding for proteins associated with the lysosomal function.
Viviana Vargas-López   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy